Healthcare professionals

Our data

Links

From clinical trials to real-world evidence

We focus on expanding the access for healthcare professionals and people living with allergies to evidence-based allergy immunotherapy as well as strengthening the evidence around burden of disease, disease modification, and new indications. Here you can explore more about our commitment to safety and efficacy of our treatment solutions for allergic disease, our key sublingual immunotherapy (SLIT) clinical trials and real-world evidence as well as sharing of our clinical data.

Clinical trials

Our clinical trials commit to investigating the safety and efficacy of specific treatment of allergy and prevention of disease in a controlled setting. Learn more about our co-operations, areas of particular interest, and completed key SLIT randomised controlled trials.

Learn more

Real-world evidence

In our real-world studies, we evaluate the safety and effectiveness of specific treatment of people living with allergy in an uncontrolled setting – the real world, where environmental, behavioural, and other every-day life factors are included. Real-world evidence is therefore increasingly used in healthcare decision making.

Learn more

Clinical data sharing

In the spirit of transparency, and in compliance with industry guidelines, we share details of our clinical trials to help health care professionals and scientists improving the understanding of allergic disease and potential treatment options.

Learn more